3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
4
Thoracic
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
CNS
1
Conditions
Myelodysplastic Syndromes
999
Leukemia, Myeloid, Acute
826
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
532
Leukemia
519
Precursor Cell Lymphoblastic Leukemia-Lymphoma
501
Myeloproliferative Disorders
438
Lymphoma, Non-Hodgkin
339
Multiple Myeloma
327
Hodgkin Disease
313
Leukemia, Lymphocytic, Chronic, B-Cell
304
Leukemia, Myelomonocytic, Chronic
299
Primary Myelofibrosis
285
Lymphoma
267
Leukemia, Myeloid, Chronic-Phase
254
Leukemia, Myeloid, Accelerated Phase
208
Blast Crisis
208
Lymphoma, Mantle-Cell
206
Lymphoma, Follicular
204
Burkitt Lymphoma
200
Lymphoma, Large B-Cell, Diffuse
192
Lymphoma, B-Cell, Marginal Zone
184
Congenital Abnormalities
166
Lymphoma, Large-Cell, Immunoblastic
165
Polycythemia Vera
162
Myelodysplastic-Myeloproliferative Diseases
159
Neoplasms, Plasma Cell
152
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
145
Anemia, Refractory, with Excess of Blasts
127
Thrombocythemia, Essential
125
Lymphoma, T-Cell, Cutaneous
124
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Chromosome Aberrations
×
Myeloid
×
Clear all
NCT00461929
2009-02-13
GIST
University Health Network, Toronto
Phase 4
Terminated
68 enrolled